The Weather Can Change in an Hour, But a Terminal Cancer Diagnosis Changes Your Life In Minutes

The symptoms of terminal pancreatic cancer are subtle. The disease is usually not diagnosed until it has substantially progressed, leaving a dismal five-year overall survival of five to ten percent.…

Continue Reading The Weather Can Change in an Hour, But a Terminal Cancer Diagnosis Changes Your Life In Minutes
Wake Forest Baptist Comprehensive Cancer Center Receives $2.5M Grant for Organoid Research
stevepb / Pixabay

Wake Forest Baptist Comprehensive Cancer Center Receives $2.5M Grant for Organoid Research

  Recently, the National Cancer Institute provided a $2.5M grant to support specialized medical research being performed at the Wake Forest Organoid Research Center (WFORCE). According to the press release,…

Continue Reading Wake Forest Baptist Comprehensive Cancer Center Receives $2.5M Grant for Organoid Research
Experimental Treatment Could be Useful in Numerous Rare and Deadly Cancers
source: pixabay.com

Experimental Treatment Could be Useful in Numerous Rare and Deadly Cancers

While novel treatments have been rapidly emerging onto the drug scene, new treatment options for pancreatic cancer have fallen behind. But now, according to OncLive’s interview with Dr. P.A. Philip,…

Continue Reading Experimental Treatment Could be Useful in Numerous Rare and Deadly Cancers
A Surgery To Treat Obesity Found to Significantly Lower Risk of Pancreatic Cancer
source: pixabay.com

A Surgery To Treat Obesity Found to Significantly Lower Risk of Pancreatic Cancer

According to EMJ, findings from an analysis spanning 20 years has found that weight loss surgery used to address obesity also significantly lowers a person's risk of developing pancreatic cancer.…

Continue Reading A Surgery To Treat Obesity Found to Significantly Lower Risk of Pancreatic Cancer
GOBLET Clinical Trial to Evaluate Pelareorep & Atezolizumab for Pancreatic, Anal Cancers
Source: Pixabay.com

GOBLET Clinical Trial to Evaluate Pelareorep & Atezolizumab for Pancreatic, Anal Cancers

According to OncLive, Oncolytics Biotech and Roche are pairing up to run a new German Phase ½ clinical trial. The GOBLET trial will evaluate pelareorep in conjunction with atezolizumab (Tecentriq)…

Continue Reading GOBLET Clinical Trial to Evaluate Pelareorep & Atezolizumab for Pancreatic, Anal Cancers
The FDA Has Provided 16 Million Dollars to Scientists to Continue Rare Disease Research During the Pandemic
source: pixabay.com

The FDA Has Provided 16 Million Dollars to Scientists to Continue Rare Disease Research During the Pandemic

 The United States FDA has just announced that they will be providing  6 new grants, which are worth 16 million dollars for rare disease research. These grants will last a…

Continue Reading The FDA Has Provided 16 Million Dollars to Scientists to Continue Rare Disease Research During the Pandemic
Scientists Screen for Pancreatic Cancer Using Artificial Intelligence
source: pixabay.com

Scientists Screen for Pancreatic Cancer Using Artificial Intelligence

  News-Medical Life Sciences recently interviewed Dr. Ananya Malhotra, Research Fellow at the London School of Hygiene, regarding her most current research involving pancreatic cancer. Dr. Malhotra believes artificial intelligence (AI)…

Continue Reading Scientists Screen for Pancreatic Cancer Using Artificial Intelligence